Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica

Target groups for human papillomavirus (HPV) vaccination are controversial. We evaluated vaccine efficacy (VE) against 1-year persistent infection, stratified by age and sexual behavior, among young women in Costa Rica. We randomized 7,466 healthy women 18 to 25 years of age to HPV16/18 or hepatitis...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Herrero, Rolando, Wacholder, Sholom, Rodríguez, Ana C., Solomon, Diane, González, Paula, Kreimer, Aimee R., Porras, Carolina, Schussler, John, Jiménez, Silvia, Sherman, Mark E., Quint, Wim, Schiller, John T., Lowy, Douglas R., Schiffman, Mark, Hildesheim, Allan
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3354733/
https://ncbi.nlm.nih.gov/pubmed/22586631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-11-0131
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares